Breakthrough trial aims to free liver patients from lifelong drugs
Disease control
Completed
This study tested whether a special cell infusion from the donor could help liver transplant patients safely stop taking lifelong anti-rejection drugs. Sixteen patients received the infusion before transplant and were then slowly taken off their standard medications over several …
Phase: PHASE1, PHASE2 • Sponsor: Angus W. Thomson PhD DSc • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC